COVID-19 Vaccine: Sputnik V Vaccine Gets Nod For Clinical Trials In India

Sputnik V, the COVID-19 vaccine made by Russia, gets the nod for clinical trials in India. Sputnik V became the first registered COVID-19 vaccine on the market.

The Drug Controller General of India (DCGI) has approved Dr. Reddy's, a global pharmaceutical company, to conduct phase 2 and 3 human clinical trials of the Sputnik V, a COVID-19 vaccine made by Russia in India.

Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and registered on August 11.

COVID-19 Vaccine: Where Do We Stand Now?
COVID-19: The biggest challenge with the pandemic lies in not only developing a successful vaccine but also producing it in quantities necessary to provide immunity to all citizens. Competition is already emerging over who will have access once a vaccine is ready.

TOP INSIGHT

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Limited had agreed to cooperate on clinical trials and distribution of Sputnik V Covid-19 vaccine in India.

Co-chairman and Managing Director of Dr Reddy's Laboratories G.V. Prasad in a statement said "This is a significant development that allows us to commence the clinical trials in India and we are committed to bringing in a safe and efficacious vaccine to combat the pandemic."

"On regulatory approval in India, RDIF shall supply to Dr Reddy's 100 million doses of the vaccine. The Sputnik V vaccine, which is based on well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the coronavirus pandemic," a statement from the Russian fund had earlier stated.

The deliveries could begin in late 2020, subject to completion of successful trials and registration of the vaccine by India's regulatory authorities, said the Russian Direct Investment Fund.

�Sputnik V� - Russia�s First Effective Vaccine Against the Novel Coronavirus
Russia successfully tested its first vaccine, named ‘Sputnik V’, against the novel coronavirus. The vaccine works very effectively and creates a stable immunity against the coronavirus, with no side-effects.

Sputnik V Covid-19 Vaccine

Sputnik V became the first registered COVID-19 vaccine on the market. The announcement created a so-called “Sputnik moment” for the global community. In 1957 the successful launch of the first space satellite by the Soviet Union reinvigorated space research. The new Russian COVID-19 vaccine is therefore called Sputnik V.

UK's COVID-19 Vaccine Could Be Ready by Christmas
In the UK, the COVID-19 vaccine could be ready by Christmas, according to the head of the country's vaccine task force.

Source-Medindia

Johnson & Johnson Stops COVID-19 Vaccine Trial Temporarily
US pharmaceutical giant Johnson & Johnson announced that it has temporarily paused its COVID-19 vaccine trial after a participant became unwell.